Pharma Journalist -

Bioverativ announced that it has successfully completed its acquisition of True North Therapeutics, a privately-held, clinical-stage rare disease biotechnology company. The acquisition…
Read More...

LivaNova announced that it received FDA approval of its VNS Therapy system in patients as young as four years of age with partial onset seizures that are refractory to antiepileptic…
Read More...

Casebia Therapeutics, the joint venture founded by Bayer and CRISPR Therapeutics, announced the hiring of Robin A. Walker as the company’s Vice President, Head of Legal. Walker is a…
Read More...

Veeva Systems announced that Santhera Pharmaceuticals selected Veeva CRM and Veeva OpenData as a commercial software and data platform for its first product launch. The rare disease…
Read More...

LifeArc, the UK medical research charity previously known as MRC Technology, The Centre for Drug Research and Development (CDRD), and the Defence Science and Technology Laboratory…
Read More...

NeuroVive Pharmaceutical AB and Yungjin Pharm Corporation Ltd announced that the clinical phase I study of KL1333 has started in Korea and that the first healthy volunteer has been…
Read More...

QS Pharma, the Contract Development and Manufacturing Organisation (CDMO), which was acquired by Quotient Clinical in February 2017, announced it has received approval from the European…
Read More...

Allergan announced the launch of the over-the-counter (OTC) artificial tear REFRESH OPTIVE MEGA-3, the latest innovation in the REFRESH portfolio that fortifies the lipid layer when…
Read More...

Breckenridge Pharmaceutical, Inc. announced that FDA has granted final approval of its ANDA Azacitidine for Injection, 100mg per vial, Single-Dose Vial, a generic version of Vidaza® by…
Read More...

Danish drugmaker Novo Nordisk said on Friday a phase 2 trial for its big hope in tackling obesity, an improved GLP-1 drug called semaglutide, showed a weight loss of up to 13.8 percent…
Read More...